The NIH and the Bill and Melinda Gates Foundation, Seattle, will invest at least $200 million over the next four years to develop affordable gene-based cures globally for sickle cell disease and HIV infection. The announcement of this timely collaboration was made during a late-morning telebriefing at NIH on October 23, 2019. Here, I met with two of my fellow participants on the call: Gary Gibbons (left), director of NIH’s Heart, Lung, and Blood Institute; and Trevor Mundel, (middle), president of the Gates Foundation’s global health efforts. Also joining the telebriefing remotely by phone were Tony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases; and Matishidiso Moeti, director of the World Health Organization’s Regional Office for Africa. Credit: NIH
Hi, my name is Shelita Winchester and I’m the mother of my only child- Patrick born in 1990 w- SS. In 2004 on ECMO, since that trauma he lives w/ 17 left side strokes 2 brain strokes and double port blood transfusion evey 3-4 wks and for the rest of his life. When I see the study @NIH with Dr. Collins it made me 😢 tears of 😂 that maybe my son could be in your trials. I work in the with the Sickle Cell foundation @ NIH a very long time ago. I 🙏 evey day every minute on every day that my can be help. Thanks Be To God that I see this study.
Hi, my name is Shelita Winchester and I’m the mother of my only child- Patrick born in 1990 w- SS. In 2004 on ECMO, since that trauma he lives w/ 17 left side strokes 2 brain strokes and double port blood transfusion evey 3-4 wks and for the rest of his life. When I see the study @NIH with Dr. Collins it made me 😢 tears of 😂 that maybe my son could be in your trials. I work in the with the Sickle Cell foundation @ NIH a very long time ago. I 🙏 evey day every minute on every day that my can be help. Thanks Be To God that I see this study.